Human cytomegalovirus infection induces leukotriene B4 and 5-lipoxygenase expression in human placentae and umbilical vein endothelial cells

Placenta

Volumn 35, Issue 6, 2014, Pages 345-350

  Benard, M ^a,b   Straat, K ^c   Omarsdottir, S ^c   Leghmari, K ^a   Bertrand, J ^d   Davrinche, C ^a   Duga Neulat, I ^d   Soderberg Naucler C ^c   Rahbar, A ^c   Casper, C ^a,b,c  

^a Université Paul Sabatier   (France)

^b HÔPITAL DES ENFANTS   (France)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d CHU PURPAN   (France)

Author keywords

5 Lipoxygenase; Endothelial cells; Histoculture; Human cytomegalovirus; LTB4; Placenta

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; IMMEDIATE EARLY ANTIGEN; LEUKOTRIENE B4; MESSENGER RNA; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS RNA; 5-HYDROXY-6,8,11,14-EICOSATETRAENOIC ACID; HYDROXYICOSATETRAENOIC ACID;

ARTICLE; CLINICAL ARTICLE; CONGENITAL INFECTION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; EX VIVO STUDY; EXPLANT; FETUS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; NONHUMAN; PLACENTA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; UMBILICAL VEIN ENDOTHELIAL CELL; CHEMISTRY; CYTOMEGALOVIRUS INFECTIONS; ENDOTHELIUM CELL; ENZYMOLOGY; FEMALE; GENETICS; METABOLISM; PREGNANCY; UMBILICAL VEIN; UPREGULATION;

ARACHIDONATE 5-LIPOXYGENASE; CYTOMEGALOVIRUS INFECTIONS; ENDOTHELIAL CELLS; FEMALE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; IMMUNOHISTOCHEMISTRY; LEUKOTRIENE B4; PLACENTA; PREGNANCY; RNA, MESSENGER; UMBILICAL VEINS; UP-REGULATION;

EID: 84900465306     PISSN: 01434004     EISSN: 15323102     Source Type: Journal    
DOI: 10.1016/j.placenta.2014.03.022     Document Type: Article

References (29)

1. S.A. Ross, and S.B. Boppana Congenital cytomegalovirus infection: outcome and diagnosis Semin Pediatr Infect Dis 16 1 2005 Jan 44 49
2. C. Wang, X. Zhang, S. Bialek, and M.J. Cannon Attribution of congenital cytomegalovirus infection to primary versus non-primary maternal infection Clin Infect Dis Off Publ Infect Dis Soc Am 52 2 2011 Jan 15 e11 13
3. S.C. Munro, D. Trincado, B. Hall, and W.D. Rawlinson Symptomatic infant characteristics of congenital cytomegalovirus disease in Australia J Paediatr Child Health 41 8 2005 Aug 449 452
4. S.B. Boppana, R.F. Pass, W.J. Britt, S. Stagno, and C.A. Alford Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality Pediatr Infect Dis J 11 2 1992 Feb 93 99
5. R.F. Pass, K.B. Fowler, S.B. Boppana, W.J. Britt, and S. Stagno Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome J Clin Virol Off Publ Pan Am Soc Clin Virol 35 2 2006 Feb 216 220
6. K. Benirschke, and P. Kaufmann Pathology of the human placenta 2nd ed. 1990 Springer-Verlag New York
7. L. Gabrielli, M.P. Bonasoni, T. Lazzarotto, S. Lega, D. Santini, and M.P. Foschini et al. Histological findings in foetuses congenitally infected by cytomegalovirus J Clin Virol Off Publ Pan Am Soc Clin Virol 46 Suppl. 4 2009 Dec S16 S21
8. A. Di Gennaro, and J.Z. Haeggström The leukotrienes: immune-modulating lipid mediators of disease Adv Immunol 116 2012 51 92
9. B. Samuelsson Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation Science 220 4597 1983 May 6 568 575
10. H. Qiu, K. Strååt, A. Rahbar, M. Wan, C. Söderberg- Nauclér, and J.Z. Haeggström Human CMV infection induces 5-lipoxygenase expression and leukotriene B4 production in vascular smooth muscle cells J Exp Med 205 1 2008 Jan 21 19 24
11. H. Lopez, M. Benard, E. Saint-Aubert, M. Baron, H. Martin, and T. Al Saati et al. Novel model of placental tissue explants infected by cytomegalovirus reveals different permissiveness in early and term placentae and inhibition of indoleamine 2,3-dioxygenase activity Placenta 32 7 2011 Jul 522 530
12. B.B. Wentworth, and L. French Plaque assay of cytomegalovirus strains of human origin Proc Soc Exp Biol Med 135 2 1970 253 258
13. L. Gabrielli, M.P. Bonasoni, D. Santini, G. Piccirilli, A. Chiereghin, and E. Petrisli et al. Congenital cytomegalovirus infection: patterns of fetal brain damage Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis 18 10 2012 Oct E419 E427
14. M. Mostoufi-zadeh, S.G. Driscoll, S.A. Biano, and R.B. Kundsin Placental evidence of cytomegalovirus infection of the fetus and neonate Arch Pathol Lab Med 108 5 1984 May 403 406
15. E. Maidji, G. Nigro, T. Tabata, S. McDonagh, N. Nozawa, and S. Shiboski et al. Antibody treatment promotes compensation for human cytomegalovirus- induced pathogenesis and a hypoxia-like condition in placentas with congenital infection Am J Pathol 177 3 2010 Sep 1298 1310
16. U. Janssen-Timmen, P.J. Vickers, U. Wittig, W.D. Lehmann, H.J. Stark, and N.E. Fusenig et al. Expression of 5-lipoxygenase in differentiating human skin keratinocytes Proc Natl Acad Sci U S A 92 15 1995 Jul 18 6966 6970
17. C.H. Lammers, P. Schweitzer, P. Facchinetti, J.M. Arrang, S.G. Madamba, and G.R. Siggins et al. Arachidonate 5-lipoxygenase and its activating protein: prominent hippocampal expression and role in somatostatin signaling J Neurochem 66 1 1996 Jan 147 152
18. S. Gredmark-Russ, M. Dzabic, A. Rahbar, A. Wanhainen, M. Björck, and E. Larsson et al. Active cytomegalovirus infection in aortic smooth muscle cells from patients with abdominal aortic aneurysm J Mol Med Berl Ger 87 4 2009 Apr 347 356
19. L. Wright, R.M. Tuder, J. Wang, C.D. Cool, R.A. Lepley, and N.F. Voelkel 5-Lipoxygenase and 5-lipoxygenase activating protein (FLAP) immunoreactivity in lungs from patients with primary pulmonary hypertension Am J Respir Crit Care Med 157 1 1998 Jan 219 229
20. N.L. Brown, D.M. Slater, S.A. Alvi, M.G. Elder, M.H. Sullivan, and P.R. Bennett Expression of 5-lipoxygenase and 5-lipoxygenase-activating protein in human fetal membranes throughout pregnancy and at term Mol Hum Reprod 5 7 1999 Jul 668 674
21. L. Pereira, E. Maidji, S. McDonagh, O. Genbacev, and S. Fisher Human cytomegalovirus transmission from the uterus to the placenta correlates with the presence of pathogenic bacteria and maternal immunity J Virol 77 24 2003 Dec 13301 13314
22. L. Pereira, E. Maidji, S. McDonagh, and T. Tabata Insights into viral transmission at the uterine-placental interface Trends Microbiol 13 4 2005 Apr 164 174
23. D. Chou, Y. Ma, J. Zhang, C. McGrath, and S. Parry Cytomegalovirus infection of trophoblast cells elicits an inflammatory response: a possible mechanism of placental dysfunction Am J Obstet Gynecol 194 2 2006 Feb 535 541
24. J.Z. Haeggström, and C.D. Funk Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease Chem Rev 111 10 2011 Oct 12 5866 5898
25. M.B. Bailie, T.J. Standiford, L.L. Laichalk, M.J. Coffey, R. Strieter, and M. Peters-Golden Leukotriene-deficient mice manifest enhanced lethality from Klebsiella pneumonia in association with decreased alveolar macrophage phagocytic and bactericidal activities J Immunol Baltim Md 1950 157 12 1996 Dec 15 5221 5224
26. J. Gosselin, P. Borgeat, and L. Flamand Leukotriene B4 protects latently infected mice against murine cytomegalovirus reactivation following allogeneic transplantation J Immunol Baltim Md 1950 174 3 2005 Feb 1 1587 1593
27. L. Flamand, M.J. Tremblay, and P. Borgeat Leukotriene B4 triggers the in vitro and in vivo release of potent antimicrobial agents J Immunol Baltim Md 1950 178 12 2007 Jun 15 8036 8045
28. L. Flamand, P. Borgeat, R. Lalonde, and J. Gosselin Release of anti-HIV mediators after administration of leukotriene B4 to humans J Infect Dis 189 11 2004 Jun 1 2001 2009
29. C. Pergola, and O. Werz 5-Lipoxygenase inhibitors: a review of recent developments and patents Expert Opin Ther Patents 20 3 2010 Mar 355 375